KCM
TMO icon

Key Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Key Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.01K Hold
8
– – ﹤0.01% 472
2026
Q1 		$3.93K Buy
+8
New +$4.34K ﹤0.01% 426

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Key Capital Management's TMO Position: Q2 2026 in Review

Key Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 8 shares worth $4.01K. The position accounts for ﹤0.01% of the portfolio, ranked #472.

Key Capital Management first reported a position in TMO in Q1 2026 and has held it in 2 quarters since. 1,515 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Key Capital Management held 8 shares of Thermo Fisher Scientific worth $4.01K as of Q2 2026.
  • Key Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up ﹤0.01% of Key Capital Management's portfolio in Q2 2026, its #472 holding.
  • Key Capital Management first reported a position in Thermo Fisher Scientific in Q1 2026 and has held it in 2 quarters since.
  • 1,515 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Key Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.